(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
NAFFIC, AWARE claim first China-EU DPP for textiles - 2Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
- 3When faith comes under fire: How Iran’s repression of religious minorities has increased
- 4Step by step instructions to Streamline Your Dozing Involvement in a Savvy Bed
- 5Iran war drives global fertilizer prices up, raising food cost fears
- The next frontier in space is closer than you think – welcome to the world of very low Earth orbit satellites
- Fisherman Attacked by Great White Shark Says ‘My Left Foot Was in His Mouth’
- She loves to give experiences. He goes for sentimental gifts. They ask an expert: What is the perfect holiday present?
- Exposure to neighborhood violence leads some Denver teens to use tobacco and alcohol earlier, new study shows
- Iran plans new restrictions in overhaul of Strait of Hormuz rules
- Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- Figure out How to Pick the Right Toothbrush for You
- 5 Morning Schedules That Stimulate Your Day
- UN rights chief: Israel's new Gaza aid agency rules 'outrageous'
